Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of August 28, 2026, CUE trades at $29.59 with a market cap of $209.58M and a P/E ratio of -0.98. CUE moved +3.16% today. Year to date, CUE is +178.21%; over the trailing twelve months it is +13.70%. Its 52-week range spans $4.97 to $52.50. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CUE, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $29.59 |
| Market Cap | $209.58M |
| P/E Ratio | -0.98 |
| EPS | $-28.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $52.50 |
| 52-Week Low | $4.97 |
| Volume | 23.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $37.65M |
| Net Income | $-164.11M |
| Gross Margin | 0.00% |
CUE analyst coverage data. Average price target: $0.00.